Novartis US’ Post

View organization page for Novartis US, graphic

88,421 followers

Multiple sclerosis (MS) affects nearly 3 million people worldwide and 1 million here in the U.S. This past week our team attended the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, where we collaborated with patient advocacy groups, including MS Views and News and Can Do MS, to facilitate important MS education programs to assist people living with MS and their care partners. We’d like to extend our thanks to all of the patient organizations for their engagement and tireless dedication to the MS community. We remain committed to our trusted partnerships, and to understanding and solving some of the most burdensome neurological conditions to improve the quality of life for patients and their caregivers. #CMSC2024

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image
    +3
George Boelman

Neurology Division Executive Sales Specialist at Novartis

3d

So incredible to witness the true passion towards assisting everyone and anyone touched by MS.

Like
Reply
USA and international Research .

Chief Executive Officer at USA and International Research Inc.

1mo

Thank you for your dedication to the MS community! Collaborating with patient advocacy groups at the CMSC Annual Meeting demonstrates your commitment to supporting those affected by MS. Together, we can make a difference in improving quality of life. #CMSC2024 #MSAwareness

Like
Reply
Bob Miller

Executive Vice President at PTI

1mo

Great way to find out what reallyhappens

Like
Reply
Anna Copeland Hall

Director, Commercial Learning & Development at Sumitomo Pharma America

1mo

fun to see you in action Ana Lewis, MD, MSHA !!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics